[Adverse effect of the intermittent use of rifampicin in treating Hansen's disease].
Papaiordanou
P M
PM
Branchini
M L
ML
Gonçales Júnior
F L
FL
Aoki
F H
FH
Boccato
R S
RS
Ramos
M de C
Mde C
Pedro
R J
RJ
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000368:Aged; D000743:Anemia, Hemolytic / Q000139:chemically induced; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced
D012293:Rifampin
Efeito adverso do uso intermitente de rifampicina para tratamento de hanseníase.